مکتبة رقمیه للعلوم الطبيه
Your cart is empty.
  • Cart
  • Lists
    Your lists Log in to create your own lists
  • Log in to your account
  • Your cookies
  • Search history
  • Advanced search
  • Authority search
  • Tag cloud
  • Library

Log in to your account

  1. Home
  2. Details for: Ertiprotafib improves glycemic control and lowers lipids via multiple mechanisms.
Normal view MARC view ISBD view

Ertiprotafib improves glycemic control and lowers lipids via multiple mechanisms. [electronic resource]

By:
  • Erbe, David V
Contributor(s):
  • Wang, Suyue
  • Zhang, Yan-Ling
  • Harding, Kimberly
  • Kung, Leslie
  • Tam, May
  • Stolz, Leslie
  • Xing, Yuzhe
  • Furey, Sarah
  • Qadri, Ariful
  • Klaman, Lori D
  • Tobin, James F
Producer: 20050328Description: 69-77 p. digitalISSN:
  • 0026-895X
Subject(s):
  • Adipocytes -- cytology
  • Animals
  • Blood Glucose -- drug effects
  • Cell Differentiation -- drug effects
  • Diabetes Mellitus, Type 2 -- drug therapy
  • Humans
  • Hypoglycemic Agents -- pharmacology
  • Hypolipidemic Agents -- pharmacology
  • Insulin -- blood
  • Kinetics
  • Lipids -- blood
  • Male
  • Mice
  • Mice, Obese
  • PPAR alpha -- genetics
  • PPAR gamma -- genetics
  • Phenylpropionates -- pharmacology
  • Protein Tyrosine Phosphatase, Non-Receptor Type 1
  • Protein Tyrosine Phosphatases -- antagonists & inhibitors
  • Recombinant Proteins -- metabolism
  • Thiophenes -- pharmacology
  • Triglycerides -- blood
Online resources:
  • Available from publisher's website
In: Molecular pharmacology vol. 67
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Cancel rating. Average rating: 0.0 (0 votes)
  • Holdings ( 0 )
  • Title notes ( 1 )
  • Comments ( 0 )
No physical items for this record

Publication Type: Journal Article

There are no comments on this title.

Log in to your account to post a comment.

Ertiprotafib improves glycemic control and lowers lipids via multiple mechanisms.

APA

Erbe D. V., Wang S., Zhang Y., Harding K., Kung L., Tam M., Stolz L., Xing Y., Furey S., Qadri A., Klaman L. D. & Tobin J. F. (20050328). Ertiprotafib improves glycemic control and lowers lipids via multiple mechanisms. : Molecular pharmacology.

Chicago

Erbe David V, Wang Suyue, Zhang Yan-Ling, Harding Kimberly, Kung Leslie, Tam May, Stolz Leslie, Xing Yuzhe, Furey Sarah, Qadri Ariful, Klaman Lori D and Tobin James F. 20050328. Ertiprotafib improves glycemic control and lowers lipids via multiple mechanisms. : Molecular pharmacology.

Harvard

Erbe D. V., Wang S., Zhang Y., Harding K., Kung L., Tam M., Stolz L., Xing Y., Furey S., Qadri A., Klaman L. D. and Tobin J. F. (20050328). Ertiprotafib improves glycemic control and lowers lipids via multiple mechanisms. : Molecular pharmacology.

MLA

Erbe David V, Wang Suyue, Zhang Yan-Ling, Harding Kimberly, Kung Leslie, Tam May, Stolz Leslie, Xing Yuzhe, Furey Sarah, Qadri Ariful, Klaman Lori D and Tobin James F. Ertiprotafib improves glycemic control and lowers lipids via multiple mechanisms. : Molecular pharmacology. 20050328.

  • Print
  • Cite
  • Add to your cart (remove)
  • Save record
    BIBTEX Dublin Core MARCXML MARC (non-Unicode/MARC-8) MARC (Unicode/UTF-8) MARC (Unicode/UTF-8, Standard) MODS (XML) RIS ISBD
  • More searches
    Search for this title in:
    Other Libraries (WorldCat) Other Databases (Google Scholar) Online Stores (Bookfinder.com) Open Library (openlibrary.org)

Exporting to Dublin Core...

Visit web site